查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
到 2030 年北美凝血市场预测 - 区域分析 - 按疾病适应症、类型、产品、技术和最终用户
市场调查报告书
商品编码
1494293

到 2030 年北美凝血市场预测 - 区域分析 - 按疾病适应症、类型、产品、技术和最终用户

North America Coagulation Market Forecast to 2030 - Regional Analysis - by Disease Indications, Type, Offering, Technology, and End User
出版日期: | 出版商: The Insight Partners | 英文 102 Pages | 订单完成后即时交付

价格

2022年北美凝血市场价值为27.1264亿美元，预计2030年将达46.3326亿美元；预计2022年至2030年复合年增长率为6.9%。

血液疾病盛行率的增加推动了北美凝血市场

根据国家罕见疾病组织的数据，A 型血友病是一种常见的 X 连锁隐性遗传疾病，也是继冯维乐布兰氏症之后第二常见的遗传性凝血因子缺乏症。此外，在美国，每 5,000 名男婴儿中就有 1 名患有 A 型血友病。根据2020 年全球血友病护理研究，随着时间的推移，全球已识别并记录了393,658 例出血性疾病病例，其中包括241,535 例血友病病例、87,729 例血管性血友病病例和64,394 例其他出血性疾病病例。根据国家医学图书馆 (NLM) 的数据，2020 年美国约有 30,000-33,000 名男性受到血友病的影响。

根据美国癌症协会(CLL) 的报告，2021 年美国记录了约21,250 例新的慢性淋巴细胞白血病病例。病人数美国受深部静脉栓塞影响的人数可能达到 90 万人（每 1,000 人中有 1 至 2 人）。同一消息来源估计，在美国，每年有 60,000-100,000 名美国人死于静脉血栓栓塞。

据美国卫生与公众服务部称，2020 年约有 10 万美国人被诊断患有镰状细胞疾病 (SCD)，这是最常见的遗传性血液疾病之一。此外，预计到2050 年，患有SCD 的人数将增加约30%。约有66 名成年人患有免疫性血小板减少症(ITP)每年到 2022 年。

北美凝固市场概况

北美凝血市场分为美国、加拿大和墨西哥。由于血液疾病发病率不断上升、心房颤动 (AFib) 等心血管疾病的发生率不断增加，以及主要市场参与者从事新产品和现有产品开发，北美占据了重要的市场份额。美国在北美凝血市场占有最大份额。血液疾病病例的不断增加、心血管疾病的盛行率不断上升以及政府对预防血液疾病的支持预计将推动 2022-2030 年北美凝血市场的成长。

北美凝固市场收入及 2030 年预测（百万美元）

北美混凝市场细分

北美凝血市场根据疾病适应症、类型、产品、技术、最终用户和国家进行细分。

根据疾病适应症，北美凝血市场分为维生素 K 缺乏症、肝病、瀰漫性血管内凝血及肺栓塞、循环抗凝血剂的发展、血友病、冯维勒布兰氏症等。 2022 年，肝病领域占据北美凝血市场最大份额。

根据类型，北美凝血市场分为临床实验室分析仪和即时检测分析仪。 2022 年，临床实验室分析仪细分市场将占据更大的北美凝血市场份额。等。

在产品方面，北美凝血市场分为诊断与治疗。至2022年，诊断细分市场将占据更大的北美凝血市场份额。 D-二聚体测试、血小板功能测试等。治疗部分进一步细分为抗纤溶药物、避孕药、去氨加压素和免疫抑制药物、维生素K 补充剂、血液稀释剂、凝血酶抑制剂或血栓溶解剂、替代疗法、导管辅助血栓清除等。

依技术划分，北美凝血市场分为光学技术、机械技术、电化学技术等。 2022 年，光学技术领域占据北美凝血市场最大份额。

依最终用户划分，北美凝血市场分为临床实验室、医院等。 2022 年，临床实验室领域占据北美凝血市场最大份额。

根据国家/地区，北美凝固市场分为美国、加拿大和墨西哥。 2022年，美国主导北美凝血市场。

Diagnostica Stago Inc、F Hoffmann-La Roche Ltd、Genrui Biotech Co., Ltd、Helena Laboratories Corporation、Horiba Ltd、ImproGen Diagnostik Kimya San。 ＆抽动。 Ltd.Sti.、Siemens Healthineers AG、Sysmex Corp 和 Transasia Bio-Medicals Ltd 是北美凝血市场的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美凝固市场 - 主要产业动态

  • 主要市场驱动因素：
    • 血液疾病盛行率增加
    • 心血管疾病盛行率上升
  • 市场限制
    • 与凝血分析仪相关的高成本
  • 市场机会
    • 主要市场参与者不断发展有机和无机策略
  • 未来的趋势
    • 即时护理 (POC) 凝血分析仪的开发
  • 影响分析

第 5 章：凝固市场 - 北美市场分析

  • 北美凝血市场收入，2022 - 2030

第 6 章：北美凝血市场 - 收入和 2030 年预测 - 按疾病适应症

  • 概述
  • 2022 年及 2030 年北美凝血市场收入份额，依疾病适应症划分 (%)
  • 维生素 K 缺乏
  • 肝病
  • 瀰漫性血管内凝血及肺栓塞
  • 循环抗凝血剂的开发
  • 血友病
  • 血管性血友病
  • 其他的

第 7 章：北美凝固市场 - 收入和 2030 年预测 - 按类型

  • 概述
  • 北美凝固市场收入份额，按类型 2022 年和 2030 年 (%)
  • 临床实验室分析仪
  • 即时检测分析仪

第 8 章：北美凝固市场 - 收入和 2030 年预测 - 透过产品

  • 概述
  • 2022 年及 2030 年北美凝固市场收入份额（按产品划分）
  • 诊断
  • 治疗

第 9 章：北美凝固市场 - 收入和 2030 年预测 - 按技术分类

  • 概述
  • 2022 年及 2030 年北美凝固市场收入份额（按技术划分）（%）
  • 光学技术
  • 机械技术
  • 电化学技术
  • 其他的

第 10 章：北美凝固市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年及 2030 年北美混凝市场收入份额（按最终用户划分）（%）
  • 临床实验室
  • 医院
  • 其他的

第 11 章：北美凝固市场 - 国家分析

  • 北美凝固市场、收入和 2030 年预测
      • 北美凝血市场（按国家）
      • 我们
      • 加拿大
      • 墨西哥

第 12 章：混凝市场产业格局

  • 概述
  • 凝固市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 13 章：公司简介

  • Siemens Healthineers AG
  • Diagnostica Stago, Inc
  • ImproGen Diagnostik Kimya San. & Tic. Ltd.Sti.
  • Sysmex Corp
  • Helena Laboratories Corporation
  • F. Hoffmann-La Roche Ltd
  • Genrui Biotech Co., Ltd.
  • Transasia Bio-Medicals Ltd
  • Horiba Ltd.

第 14 章：附录

Product Code: BMIRE00029854

The North America coagulation market was valued at US$ 2,712.64 million in 2022 and is expected to reach US$ 4,633.26 million by 2030; it is estimated to grow at a CAGR of 6.9% from 2022 to 2030.

Increasing Prevalence of Blood Disorders Fuel North America Coagulation Market

Hemophilia A is one of the common X-linked recessive disorders and the second most common inherited clotting factor deficiency after von Willebrand disease, according to the National Organization of Rare Disorders. Also, ~1 in 5,000 male infants suffers from hemophilia A in the US. According to the Global Hemophilia Care 2020 study, 393,658 bleeding disorders cases have been recognized and documented worldwide over time, including 241,535 hemophilia cases, 87,729 von Willebrand disease cases, and 64,394 other bleeding disorder cases. According to the National Library of Medicine (NLM), ~30,000-33,000 men were affected by hemophilia in the US in 2020.

As per the reports from the American Cancer Society (CLL), the US recorded ~21,250 new cases of chronic lymphocytic leukemia in 2021. A February 2020 update from the Centers for Disease Control and Prevention (CDC) states that the number of people in the US affected by deep vein thrombosis could reach 900,000 (1 to 2 per 1,000). The same source estimates that in the US 60,000-100,000 Americans die yearly from venous thromboembolism.

According to the US Department of Health & Human Services, ~100,000 Americans were diagnosed with sickle cell disease (SCD) in 2020, which is one of the most commonly inherited blood disorders. In addition, the number of people suffering from SCD is expected to grow by ~30% by 2050. The National Organization for Rare Disorders stated that immune thrombocytopenia (ITP), an autoimmune bleeding disorder, affected ~66 adults per 1 million in the US each year in 2022. Therefore, the rising prevalence of blood disorders drives the coagulation market growth.

North America Coagulation Market Overview

The North America coagulation market is segmented into the US, Canada, and Mexico. North America accounts for a significant market share owing to the growing incidences of blood disorders, increasing occurrence of cardiovascular diseases such as atrial fibrillation (AFib), and the presence of major market players engaged in new and existing product developments. The US holds the largest share of the coagulation market in North America. The burgeoning cases of blood disorders, growing prevalence of cardiovascular diseases, and government support for preventing blood disorders are anticipated to boost the North America coagulation market growth during 2022-2030.

North America Coagulation Market Revenue and Forecast to 2030 (US$ Million)

North America Coagulation Market Segmentation

The North America coagulation market is segmented based on disease indication, type, offering, technology, end user, and country.

Based on disease indication, the North America coagulation market is segmented into vitamin k deficiency, liver disease, disseminated intravascular coagulation and pulmonary embolism, development of circulating anticoagulants, hemophilia, von willebrand's disease, and others. The liver disease segment held the largest North America coagulation market share in 2022.

Based on type, the North America coagulation market is bifurcated into clinical laboratory analysers and point-of-care testing analyzers. The clinical laboratory analysers segment held a larger North America coagulation market share in 2022. Clinical laboratory analysers segment is further subsegmented into controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others.

In terms of offering, the North America coagulation market is bifurcated into diagnosis and treatment. The diagnosis segment held a larger North America coagulation market share in 2022. Diagnosis segment is further subsegmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimmer testing, platelets function testing, and others. Treatment segment is further subsegmented into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin k supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapy, catheter-assisted thrombus removal, and others.

By technology, the North America coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. The optical technology segment held the largest North America coagulation market share in 2022.

By end user, the North America coagulation market is segmented into clinical laboratories, hospitals, and others. The clinical laboratories segment held the largest North America coagulation market share in 2022.

Based on country, the North America coagulation market is categorized into the US, Canada, and Mexico. The US dominated the North America coagulation market in 2022.

Diagnostica Stago Inc, F Hoffmann-La Roche Ltd, Genrui Biotech Co, Ltd, Helena Laboratories Corporation, Horiba Ltd, ImproGen Diagnostik Kimya San. & Tic. Ltd.Sti., Siemens Healthineers AG, Sysmex Corp, and Transasia Bio-Medicals Ltd are some of the leading companies operating in the North America coagulation market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Coagulation Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Increasing Prevalence of Blood Disorders
    • 4.1.2 Rising Prevalence of Cardiovascular Diseases
  • 4.2 Market Restraints
    • 4.2.1 High Costs Associated with Coagulation Analyzers
  • 4.3 Market Opportunities
    • 4.3.1 Growing Organic and Inorganic Strategies by Key Market Players
  • 4.4 Future Trends
    • 4.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
  • 4.5 Impact Analysis

5. Coagulation Market - North America Market Analysis

  • 5.1 North America Coagulation Market Revenue (US$ million), 2022 - 2030

6. North America Coagulation Market - Revenue and Forecast to 2030 - by Disease Indication

  • 6.1 Overview
  • 6.2 North America Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • 6.3 Vitamin K Deficiency
    • 6.3.1 Overview
    • 6.3.2 Vitamin K Deficiency: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Liver Disease
    • 6.4.1 Overview
    • 6.4.2 Liver Disease: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
    • 6.5.1 Overview
    • 6.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Development of Circulating Anticoagulant
    • 6.6.1 Overview
    • 6.6.2 Development of Circulating Anticoagulant: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Hemophilia
    • 6.7.1 Overview
    • 6.7.2 Hemophilia: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Von Willebrand's Disease
    • 6.8.1 Overview
    • 6.8.2 Von Willebrand's Disease: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.9 Others
    • 6.9.1 Overview
    • 6.9.2 Others: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Coagulation Market - Revenue and Forecast to 2030 - by Type

  • 7.1 Overview
  • 7.2 North America Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
  • 7.3 Clinical Laboratory Analyzers
    • 7.3.1 Overview
    • 7.3.2 Clinical Laboratory Analyzers: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 North America Coagulation Market, by Clinical Laboratory Analyzers
  • 7.4 Point-of-Care Testing Analyzers
    • 7.4.1 Overview
    • 7.4.2 Point-of-Care Testing Analyzers: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Coagulation Market - Revenue and Forecast to 2030 - by Offering

  • 8.1 Overview
  • 8.2 North America Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
  • 8.3 Diagnosis
    • 8.3.1 Overview
    • 8.3.2 Diagnosis: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.1 North America Coagulation Market, by Diagnosis
  • 8.4 Treatment
    • 8.4.1 Overview
    • 8.4.2 Treatment: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.4.2.1 North America Coagulation Market, by Treatment

9. North America Coagulation Market - Revenue and Forecast to 2030 - by Technology

  • 9.1 Overview
  • 9.2 North America Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
  • 9.3 Optical Technology
    • 9.3.1 Overview
    • 9.3.2 Optical Technology: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Mechanical Technology
    • 9.4.1 Overview
    • 9.4.2 Mechanical Technology: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Electrochemical Technology
    • 9.5.1 Overview
    • 9.5.2 Electrochemical Technology: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Coagulation Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 North America Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
  • 10.3 Clinical Laboratories
    • 10.3.1 Overview
    • 10.3.2 Clinical Laboratories: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Hospitals
    • 10.4.1 Overview
    • 10.4.2 Hospitals: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Coagulation Market - Country Analysis

  • 11.1 North America Coagulation Market, Revenue and Forecast to 2030
      • 11.1.1.1 North America Coagulation Market, by Country
      • 11.1.1.2 US
        • 11.1.1.2.1 Overview
        • 11.1.1.2.2 US Coagulation Market Revenue and Forecast to 2030 (US$ million)
        • 11.1.1.2.3 US Coagulation Market, by Disease Indication
        • 11.1.1.2.4 US Coagulation Market, by Type
        • 11.1.1.2.4.1 US Coagulation Market, by Clinical Laboratory Analyzers
        • 11.1.1.2.5 US Coagulation Market, by Offering
        • 11.1.1.2.5.1 US Coagulation Market, by Diagnosis
        • 11.1.1.2.5.2 US Coagulation Market, by Treatment
        • 11.1.1.2.6 US Coagulation Market, by Technology
        • 11.1.1.2.7 US Coagulation Market, by End User
      • 11.1.1.3 Canada
        • 11.1.1.3.1 Overview
        • 11.1.1.3.2 Canada Coagulation Market Revenue and Forecast to 2030 (US$ million)
        • 11.1.1.3.3 Canada Coagulation Market, by Disease Indication
        • 11.1.1.3.4 Canada Coagulation Market, by Type
        • 11.1.1.3.4.1 Canada Coagulation Market, by Clinical Laboratory Analyzers
        • 11.1.1.3.5 Canada Coagulation Market, by Offering
        • 11.1.1.3.5.1 Canada Coagulation Market, by Diagnosis
        • 11.1.1.3.5.2 Canada Coagulation Market, by Treatment
        • 11.1.1.3.6 Canada Coagulation Market, by Technology
        • 11.1.1.3.7 Canada Coagulation Market, by End User
      • 11.1.1.4 Mexico
        • 11.1.1.4.1 Overview
        • 11.1.1.4.2 Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million)
        • 11.1.1.4.3 Mexico Coagulation Market, by Disease Indication
        • 11.1.1.4.4 Mexico Coagulation Market, by Type
        • 11.1.1.4.4.1 Mexico Coagulation Market, by Clinical Laboratory Analyzers
        • 11.1.1.4.5 Mexico Coagulation Market, by Offering
        • 11.1.1.4.5.1 Mexico Coagulation Market, by Diagnosis
        • 11.1.1.4.5.2 US Coagulation Market, by Treatment
        • 11.1.1.4.6 Mexico Coagulation Market, by Technology
        • 11.1.1.4.7 Mexico Coagulation Market, by End User

12. Coagulation Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Coagulation Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Siemens Healthineers AG
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Diagnostica Stago, Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 ImproGen Diagnostik Kimya San. & Tic. Ltd.Sti.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Sysmex Corp
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Helena Laboratories Corporation
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 F. Hoffmann-La Roche Ltd
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Genrui Biotech Co., Ltd.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Transasia Bio-Medicals Ltd
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Horiba Ltd.
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Coagulation Market Segmentation
  • Table 2. North America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
  • Table 3. North America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
  • Table 4. North America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
  • Table 5. Optical Technologies and Their Applications
  • Table 6. Mechanical Technologies and Their Applications
  • Table 7. US Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
  • Table 8. US Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
  • Table 9. US Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
  • Table 10. US Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
  • Table 11. US Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
  • Table 12. US Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
  • Table 13. US Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
  • Table 14. US Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
  • Table 15. Canada Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
  • Table 16. Canada Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
  • Table 17. Canada Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
  • Table 18. Canada Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
  • Table 19. Canada Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
  • Table 20. Canada Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
  • Table 21. Canada Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
  • Table 22. Canada Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
  • Table 23. Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
  • Table 24. Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
  • Table 25. Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
  • Table 26. Mexico Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
  • Table 27. Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
  • Table 28. US Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
  • Table 29. Mexico Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
  • Table 30. Mexico Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
  • Table 31. Recent Inorganic Growth Strategies in the Coagulation Market
  • Table 32. Recent Organic Growth Strategies in the Coagulation Market
  • Table 33. Glossary of Terms, Coagulation Market

List Of Figures

  • Figure 1. North America Coagulation Market Segmentation, By Country
  • Figure 2. North America Coagulation Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Coagulation Market Revenue (US$ million), 2020 - 2030
  • Figure 5. North America Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • Figure 6. Vitamin K Deficiency: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Liver Disease: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Disseminated Intravascular Coagulation and Pulmonary Embolism: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Development of Circulating Anticoagulant: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Hemophilia: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Von Willebrand's Disease: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Others: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. North America Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 14. Clinical Laboratory Analyzers: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Point-of-Care Testing Analyzers: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. North America Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
  • Figure 17. Diagnosis: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Treatment: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. North America Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 20. Optical Technology: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Mechanical Technology: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Electrochemical Technology: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Others: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. North America Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 25. Clinical Laboratories: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Hospitals: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Others: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. North America Coagulation Market, 2022 (US$)(million)
  • Figure 29. North America Coagulation Market, By Key Countries, 2022 and 2030 (%)
  • Figure 30. US Coagulation Market Revenue and Forecast to 2030 (US$ million)
  • Figure 31. Canada Coagulation Market Revenue and Forecast to 2030 (US$ million)
  • Figure 32. Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million)
  • Figure 33. Growth Strategies in the Coagulation Market